Are there specific liver function tests to prioritize during tigecycline therapy?

Yes—during tigecycline therapy it’s smart to prioritize liver-focused monitoring, especially because hepatotoxicity (including transaminase elevations and occasional bilirubin/ALP changes) has been reported.

Liver function tests to prioritize

1. ALT and AST (transaminases)

   • These are usually the earliest and most sensitive indicators of hepatic injury.

2. Total bilirubin (± direct bilirubin if available)

   • Important for assessing more clinically meaningful impairment.

3. Alkaline phosphatase (ALP)

   • Helps distinguish a cholestatic pattern when present.

4. Albumin and INR (or PT)

   • Not always checked routinely day-to-day, but they become more relevant if you’re monitoring for synthetic liver dysfunction or if abnormalities are worsening.

5. Comprehensive CMP/LFT panel

   • In practice, many clinicians follow a panel that includes ALT/AST, bilirubin, ALP, and sometimes albumin along with other electrolytes.

What to do practically (typical approach)

• Baseline LFTs (ALT/AST, bilirubin, ALP) before starting.
• Then repeat periodically (commonly at least weekly, and more often if abnormal at baseline, worsening infection/clinical status, concomitant hepatotoxic drugs, or higher-risk patients).
• Escalate monitoring if you see rising ALT/AST or any increase in bilirubin.

If abnormalities occur

• The key is whether it’s a mild lab rise vs evidence of clinically significant injury, especially with:
  • rising bilirubin,
  • signs of jaundice,
  • or worsening INR/albumin (suggesting impaired function).
• Clinicians often follow institutional guidance and/or product labeling thresholds for holding or stopping, particularly if there’s concurrent bilirubin elevation.

Quick question (so I can tailor advice)

Are you asking for a general monitoring plan (e.g., baseline + frequency), or do you have specific lab values while on tigecycline (ALT/AST, bilirubin, ALP) that you want interpreted?